Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...
Gagal Menang, Persiba Balikpapan Dibekuk 0-1 oleh Sumut United, Klasemen Liga Nusantara Terbaru
Sumut United mencetak gol pada laga 6 besar Grup Y Liga Nusantara yang berlangsung di Stadion Sultan Agung, Bantul, Sabtu (12 ...
Japan's Inpex targets FID for Indonesia's Abadi LNG project in 2027
Japan's biggest oil and gas explorer, Inpex Corp , said on Thursday it aims to make a final investment decision (FID) on its ...